Precision Medicine

High-throughput genomic analyses may improve outcomes in patients with types of metastatic cancer, according to results of a recent trial published in Cancer Discovery.
A RNA-based digital polymerase chain reaction (PCR) method for analyzing circulating tumor cells greatly improves accuracy in diagnosing hepatocellular carcinoma (HCC), according to a report published in PNAS.
A combination of genomic assays could be an effective precision medicine approach for clinical diagnosis, prognosis, and treatment of pediatric brain tumors.
Breast cancer serves as a model for using precision medicine to guide treatment decisions and improve patients’ quality of life, according to a presentation at the 2016 Lynn Sage Breast Cancer Symposium.